T-Cell Cancer after CAR T-Cell Therapy

Abstract excerpt

The last three decades have seen dramatic advances in the use of immunotherapies to treat cancer, primarily in the form of monoclonal antibodies targeting cancer cells directly or recruiting the immune system against them. More recently, immune cells themselves are being used as anticancer treatments, led by chimeric antigen receptor (CAR) T cells, genetically modified autologous T cells that are manufactured to...

Topics

Join the communities discussing this publication.

• CAR-T cell therapy research
• Viral Infectious Diseases and Gene Expression in Insects
• Virus-based gene therapy research